Why Is ImmunityBio, Inc. (IBRX) Up 11% Today?
Biotech's biggest mover today
ImmunityBio, Inc. is the biggest Biotech gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.
Latest updates
- October 7, 2026, 11:31 AM ET
There is fresh data on file. October 7th, 2026: IBRX qualified again, up +10.8%.
At a glanceMove today+10.8%Price$10.29Market cap$10.77 billionVolume vs average3.2x52-week high$12.4352-week low$1.95Source: Market data · InsiderBuying.com - October 7, 2026, 11:00 AM ET
The record for this page moved. October 7th, 2026: IBRX qualified again, up +10.8%.
- October 7, 2026, 10:26 AM ET
October 7th, 2026: IBRX qualified again, up +10.8%.
The move
IBRX trades at $10.29, up +10.8% on the session, with a market capitalisation of $10.77 billion.
Volume is 3.2 times the 30-day average, which is the part of a move that tells you whether anyone turned up for it.
Against its 52-week range of $1.95 to $12.43, today's price sits 80% of the way up it.
No company news on file
There is no company filing, analyst action or insider transaction on our record to explain today's move.
For context, Biotech names are up an average of -0.7% today, so some of this is the sector rather than the company.
A move without a disclosed cause is common and not sinister. It is simply a move we cannot explain, and saying so is more useful than guessing.
| Metric | Value | Context |
|---|---|---|
| Change today | +10.8% | Biotech average -0.7% |
| Volume | 31,128,179 | 3.2x the 30-day average |
| Market cap | $10.77 billion | Biotechnology |
| Range | $1.95 – $12.43 | 52 weeks |
What insiders have been doing
2 open-market insider transactions are on file for the last 90 days.
Insider activity before a move is the one piece of context that carries money behind it rather than an opinion.
It is also disclosed late, so proximity to today's move should not be read as foreknowledge.
| Metric | Value | Context |
|---|---|---|
| Change today | +10.8% | Biotech average -0.7% |
| Volume | 31,128,179 | 3.2x the 30-day average |
| Market cap | $10.77 billion | Biotechnology |
| Range | $1.95 – $12.43 | 52 weeks |
The bottom line
A large move with no disclosed cause. That is worth knowing, and it is not a reason to act. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data.